Publication | Closed Access
Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance
66
Citations
24
References
2018
Year
Molecular PharmacologyMedicinal ChemistryMedicinePharmacotherapyAntimicrobial ChemotherapyAnti-cancer AgentPharmacologyDrug DiscoveryDrug Resistance
| Year | Citations | |
|---|---|---|
Page 1
Page 1